Cargando…
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
Cognitive decline due to Alzheimer’s disease (AD) is frequent in the geriatric population, which has been disproportionately affected by the COVID-19 pandemic. In this study, we investigated the levels of angiotensin-converting enzyme 2 (ACE2), a regulator of the renin-angiotensin system and the mai...
Autores principales: | Reveret, Louise, Leclerc, Manon, Emond, Vincent, Tremblay, Cyntia, Loiselle, Andréanne, Bourassa, Philippe, Bennett, David A., Hébert, Sébastien S., Calon, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544218/ https://www.ncbi.nlm.nih.gov/pubmed/37784209 http://dx.doi.org/10.1186/s40478-023-01647-1 |
Ejemplares similares
-
Higher Angiotensin I Converting Enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Louise, Reveret, et al.
Publicado: (2023) -
Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
por: Reveret, Louise, et al.
Publicado: (2023) -
Cerebrovascular insulin receptors are defective in Alzheimer’s disease
por: Leclerc, Manon, et al.
Publicado: (2022) -
Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology
por: Tournissac, Marine, et al.
Publicado: (2018) -
Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice
por: Arsenault, Dany, et al.
Publicado: (2020)